Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 22, 2026

Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels

View original at globenewswire.com
Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels Dubai, UAE, March 22, 2026 (GLOBE NEWSWIRE) -- Pepeto just passed the $8.28M mark, and the project is growing faster than anything the meme coin space has seen this year…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There will be two interest rate cuts in 2026

    60% confidence

  • What Pepeto built is something DeFi has been missing for years. One platform that trades across Ethereum, BNB Chain, and Solana with zero fees, moves tokens between all three chains instantly at no cost, and runs AI that catches scam contracts before they ever reach the user. No one else has shipped all of that in one place before a listing. That is why whale wallets, the same kind that built life changing money buying bitcoin before the rest of the world showed up, are entering the Pepeto presale with serious size.

    60% confidence

  • Bitcoin price target of $150,000 is more reasonable than $0, with many expecting $200,000 before the cycle ends

    60% confidence

  • Bitcoin price will reach $150,000

    60% confidence

  • Cryptocurrency is a digital commodity, not a security

    60% confidence

  • Pepeto has the same viral energy Shiba Inu had plus real exchange tools Shiba Inu never built

    60% confidence

  • Cryptocurrency is a digital commodity, not a security

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels — Source | Via News | ViaNews EU